FrancophonIA/ELRC3.0 huggingface dataset:
English: Pharmacotherapeutic group: Immunologicals for bovidae, inactivated bacterial vaccines for cattle.
Slovenian: Farmakoterapevtska skupina: Imunološka zdravila za votloroge (bovidae), inaktivirana bakterijska cepiva za govedo.
English: Store and transport refrigerated (2 ºC - 8 °C) and protected from light.
Slovenian: Posebna navodila za shranjevanje Shranjujte in prevažajte v hladilniku (2°C - 8 °C) in zaščitite pred svetlobo.
English: Overdose (symptoms, emergency procedures, antidotes): No information is available.
Slovenian: Preveliko odmerjanje (simptomi, nujni ukrepi, protistrupi): Ni podatkov.
English: LTA from BAC of Streptococcus uberis, strain 5616 Relative Potency ≥ 1 RPU
Slovenian: LTA iz BAC bakterije Streptococcus uberis, sev 5616 Relativna Potenca ≥ 1 RPU
English: Subunit vaccine to stimulate active immunity against Streptococcus uberis.
Slovenian: Podenota cepiva za spodbujanje aktivne imunizacije proti Streptococcus uberis.
English: Allow the vaccine to reach a temperature of +15 to + 25 °C before administration.
Slovenian: Pustite, da se cepivo pred uporabo ogreje na temperaturo med +15 in +25 °C.
English: Bearing in mind that some cows had suffered more than one episode of Streptococcus uberis clinical intramammary infection, the incidence of cows with clinical intramammary infection was 52.5% lower in the vaccinated group than those of the placebo group (4.7% versus 9.9%), with a statistical significance of p<0.017.
Slovenian: Ob upoštevanju dejstva, da so nekatere krave preživele več kot eno epizodo klinične intramamarne okužbe s Streptococcus uberis, je bila pojavnost pri kravah s klinično intramamarno okužbo za 52,5 % nižja v skupini, ki je prejela cepivo, kot pri skupini, ki je prejela placebo (4,7 % v primerjavi z 9,9 %), s statistično značilnostjo p < 0,017.
English: Administer one dose (2 ml) by deep intramuscular injection in the neck muscles according to the following immunisation program: - First dose at approximately 60 days before the expected parturition date
Slovenian: En odmerek (2 ml) dajte z globoko intramuskularno injekcijo v vratno mišičevje v skladu z naslednjim programom cepljenja: - prvi odmerek približno 60 dni pred predvidenim datumom telitve.
English: In a multicentre field study, the incidence of new cases of Streptococcus uberis clinical intramammary infection in the group vaccinated with UBAC was 50% lower than the incidence in the placebo group (6.1% versus 12.2%) which was statistically significantly different (p=0.012).
Slovenian: V multicentrični študiji na terenu je bila pojavnost novih primerov klinične intramamarne okužbe s Streptococcus uberis v skupini, ki je bila cepljena z UBAC, za 50 % nižja kot pojavnost v placebo skupini (6,1 % v primerjavi z 12,2 %), kar je bilo statistično značilno zelo različno (p = 0,012).
English: - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated)
Slovenian: Pogostost neželenih učinkov je določena po naslednjem dogovoru: - zelo pogosti (neželeni učinki se pokažejo pri več kot 1 od 10 zdravljenih živali) - pogosti (pri več kot 1, toda manj kot 10 živali od 100 zdravljenih živali) - občasni (pri več kot 1, toda manj kot 10 živali od 1.000 zdravljenih živali) - redki (pri več kot 1, toda manj kot 10 živali od 10.000 zdravljenih živali) - zelo redki (pri manj kot 1 živali od 10.000 zdravljenih živali, vključno s posameznimi primeri).
English: Carretera C63 Km 48, 300, Poligono Industrial El Rieral 17170 Amer (Girona) Spain
Slovenian: Carretera C63 Km 48,300, Polígono Industrial El Rieral 17170 Amer (Girona) Španija
English: Special warnings for each target species: Only healthy animals should be immunised.
Slovenian: POSEBNO(A) OPOZORILO(A) Posebna opozorila za vsako ciljno živalsko vrsto: Imuniziralo naj se samo zdrave živali.
English: Name and address of the manufacturer of the biological active substance:
Slovenian: Ime in naslov proizvajalca biološke učinkovine
English: Type I colourless glass vials of 3 ml.
Slovenian: 3 ml brezbarvne viale iz stekla tipa I.
English: Date of first authorisation: <{DD/MM/YYYY}>
Slovenian: Datum pridobitve dovoljenja za promet: {DD/MM/LLLL}
English: Polyethylene (PET) vials of 10, 50 and 100 ml.
Slovenian: Polietilenske (PET) viale z vsebino 10, 50 in 100 ml.
English: Local swelling more than 5 cm in diameter at the injection site is a very common reaction after administration of the vaccine.
Slovenian: Po dajanju cepiva je zelo pogosta reakcija lokalna oteklina s premerom več kot 5 cm na mestu injiciranja.
English: 1 dose (2 ml) 5 doses (10 ml)
Slovenian: 1 odmerek (2 ml) 5 odmerkov (10 ml)
English: Monophosphoryl Lipid A (MPLA) Disodium phosphate dodecahydrate Potassium dihydrogen phosphate
Slovenian: Seznam pomožnih snovi montanid ISA monofosforil lipid A (MPLA) natrijev hidrogenfosfat dodekahidrat kalijev dihidrogenfosfat natrijev klorid kalijev klorid voda za injekcije
English: UBAC emulsion for injection for cattle
Slovenian: UBAC emulzija za injiciranje za govedo
English: Special precautions to be taken by the person administering the veterinary medicinal product to animals To the user:
Slovenian: Posebni previdnostni ukrepi, ki jih mora izvajati oseba, ki živalim daje zdravilo:
English: Immunisation has to be considered as one component in a complex intramammary infection control program that addresses all important udder health factors (e.g. milking technique, dry-off and breeding management, hygiene, nutrition, housing, bedding, cow comfort, air and water quality and health monitoring) and other management practices.
Slovenian: upravljanje presuševanja in razploda, higiena, hrana, nastanitev, nastilj, udobje krav, kakovost zraka in vode, spremljanje zdravja) in druge načine upravljanja.
English: Vial of 25 and 50 doses.
Slovenian: Viala s 25 ali 50 odmerki.
English: Vial label 1 dose and 5 doses
Slovenian: Nalepka na viali po 1 odmerek in 5 odmerkov
English: 25 doses (1 vial of 50 ml) 50 doses (1 vial of 100 ml) 25 doses (50 ml) 50 doses (100 ml)
Slovenian: 20 x 1 odmerek (1 viala z 2 ml) 5 odmerkov (1 viala s 10 ml) 25 odmerkov (1 viala s 50 ml) 50 odmerkov (1 viala s 100 ml) 25 odmerkov (50 ml) 50 odmerkov (100 ml)
English: Cardboard box with 20 glass vials of 1 dose.
Slovenian: - kartonska škatla z 20 steklenimi vialami po 1 odmerkom.
English: Lipoteichoic acid (LTA) from Biofilm Adhesion Component (BAC) of Streptococcus uberis, strain 5616 .................................................................................................................................. ≥ 1 RPU*
Slovenian: lipoteihojska kislina (LTA) iz komponente lepljivega biofilma (Biofilm Adhesion Component - BAC) bakterije Streptococcus uberis, sev 5616 ................................................................................... ≥ 1 RPU* *Enote relativne potence (ELISA)
English: Cardboard box with 20 glass vials of 1 dose (2 ml).
Slovenian: Kartonska škatla z 20 steklenimi vialami z 1 odmerkom (2 ml).
English: Cardboard box with 1 PET vial of 5, 25 and 50 doses.
Slovenian: - kartonska škatla z 1 PET vialo po 5, 25 in 50 odmerki.
English: IMMUNOLOGICAL PROPERTIES
Slovenian: MUNOLOŠKE LASTNOSTI
English: 17170- AMER (Girona) SPAIN
Slovenian: 17170- AMER (Girona) Španija
English: Do not use this veterinary medicinal product after the expiry date which is stated on the label after EXP.
Slovenian: Ne uporabljajte po datumu izteka roka uporabnosti, ki je naveden na ovojnini po EXP. Rok uporabnosti zdravila v pakiranju za prodajo: 2 leti
English: For active immunisation of healthy cows and heifers to reduce the incidence of clinical intramammary infections caused by Streptococcus uberis, to reduce the somatic cell count in
Slovenian: INDIKACIJA(E) Za aktivno imunizacijo zdravih krav in telic za zmanjšanje pojavnosti kliničnih intramamarnih okužb, ki jih povzroča Streptococcus uberis, in za zmanjšanje števila somatskih celic v vzorcih mleka z četrtin vimen pozitivnih na Streptococcus uberis, in za zmanjšanje izgub pri proizvodnji mleka, ki so posledica intramamarnih okužb, ki jih povzroča Streptococcus uberis.
English: Vaccinate only healthy animals.
Slovenian: Posebni previdnostni ukrepi za uporabo pri živalih Cepite samo zdrave živali.
English: - First dose at approximately 60 days before the expected parturition date - Second dose at least 21 days before the expected parturition date - Third dose should be administered about 15 days after the calving.
Slovenian: - drugi odmerek najmanj 21 dni pred predvidenim datumom telitve.
English: Montanide ISA ............................................................................................................................907.1 mg
Slovenian: Montanid ISA ..............................................................................................................................907,1 mg Monofosforil lipid A (MPLA)
English: One dose (2 ml) contains: Lipoteichoic acid (LTA) from Biofilm Adhesion Component (BAC) of Streptococcus uberis, strain
Slovenian: En odmerek (2 ml) vsebuje: lipoteihojska kislina (LTA) iz komponente lepljivega biofilma (Biofilm Adhesion Component - BAC) bakterije Streptococcus uberis, sev 5616 ................................................................... ≥ 1 RPU* *Enote relativne potence (ELISA)
English: A transient increase in rectal temperature (mean increase of 1°C but may be up to 2°C in individual animals) may very commonly occur in the first 24 hours after injection.
Slovenian: (povprečno povečanje za 1 °C, pri določenih živalih je lahko tudi do 2 °C).
English: - Second dose at least 21 days before the expected parturition date - Third dose should be administered about 15 days after the calving.
Slovenian: - tretji odmerek je treba aplicirati približno 15 dni po telitvi.
English: Cardboard box with 1 PET vial of 50 doses (100 ml).
Slovenian: Kartonska škatla z 1 PET vialo s 50 odmerki (100 ml).
English: Cardboard box with 1 PET vial of 5 doses (10 ml).
Slovenian: Kartonska škatla z 1 PET vialo s 5 odmerki (10 ml).
English: Cardboard box with 1 PET vial of 25 doses (50 ml).
Slovenian: Kartonska škatla z 1 PET vialo s 25 odmerki (50 ml).
English: Tel: (+49) 211 698236 - 0
Slovenian: HIPRA DEUTSCHLAND GmbH Tel: (+49) 211 698236 - 0
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND
Slovenian: A. PROIZVAJALEC BIOLOŠKE (BIOLOŠKIH) UČINKOVINE IN PROIZVAJALEC ZDRAVILA, ODGOVOREN ZA SPROŠČANJE SERIJ
English: A transient increase in rectal temperature (mean increase of 1 °C but may be up to 2 °C in individual animals) may very commonly occur in the first 24 hours after injection.
Slovenian: V prvih 24 urah po injekciji se zelo pogosto pojavi prehodno povečanje rektalne temperature
English: La Selva, 135 17170 Amer (Girona) Spain
Slovenian: 17170 Amer (Girona) Španija
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, applicants in the member states
Slovenian: Seznam imen, farmacevtskih oblik, jakosti zdravila, poti uporabe zdravila,
English: Diclofenac ALTERGON 50 mg
Slovenian: Diclofenac ALTERGON 50 mg 50 mg Tableta
English: After first opening: 7 months
Slovenian: Po prvem odprtju: 7 mesecev.
English: Do not use after 7 months of first opening the bottle.
Slovenian: Ne uporabljajte več kot 7 mesecev po prvem odprtju steklenice.
English: Then CLcr is adjusted for body surface area (BSA) as follows:
Slovenian: CLcr je prilagojen na telesno površino (BSA - »body surface area«) na sledeč način:
English: Abnormal and aggressive behaviours
Slovenian: Nenormalno in nasilno vedenje
English: It also contains maltitol liquid; patients with rare hereditary problems of fructose intolerance should not take this medicinal product.
Slovenian: Vsebuje tudi raztopino maltitola; bolniki z redko prirojeno intoleranco za fruktozo ne smejo jemati tega zdravila.
English: • Close the bottle with the plastic screw cap.
Slovenian: • Zaprite steklenico s plastično navojno zaporko.
English: If such behaviours are noticed, treatment adaptation or gradual discontinuation should be considered.
Slovenian: Če so take spremembe vedenja opažene, je treba razmisliti o prilagoditvi zdravljenja ali postopni prekinitvi zdravljenja.
English: • Drink the whole contents of the glass/baby's bottle.
Slovenian: • Popijte celotno vsebino kozarca/steklenice za hranjenje otrok.
English: Date of first authorisation: 29 September 2000 Date of latest renewal: 20 August 2015
Slovenian: DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM Datum prve odobritve: 29. september 2000 Datum zadnjega podaljšanja: 20. avgust 2015
English: • Abnormal thoughts, feeling irritable or reacting more aggressively than usually, or if you or your family and friends notice important changes in mood or behaviour.
Slovenian: • Nenormalno razmišljanje, občutek razdraženosti ali bolj nasilno odzivanje, kot običajno, ali če vi ali vaša družina in prijatelji opazite pomembne spremembe razpoloženja ali vedenja.
English: Tell your doctor or pharmacist if any of the following side effects gets serious or last longer than a few days:
Slovenian: Obvestite zdravnika ali farmacevta, če kateri koli od naslednjih neželenih učinkov postane resen ali traja dlje kot nekaj dni:
English: Dose and frequency
Slovenian: odmerjanje in pogostnost
English: As with all antiepileptic medicines, sudden discontinuation of levetiracetam should be avoided as this may lead to breakthrough seizures that could have serious consequences for the woman and the unborn child.
Slovenian: Kot pri vseh drugih antiepileptikih se je treba nenadni prekinitvi uporabe levetiracetama izogniti, saj lahko to povzroči izbruh napadov, ki imajo lahko resne posledice za žensko in nerojenega otroka.
English: A doctor or a nurse will administer you Keppra as an intravenous infusion.
Slovenian: Zdravnik ali medicinska sestra vam bodo zdravilo Keppra dali kot intravensko infuzijo.
English: Adverse reactions are presented in the order of decreasing seriousness and their frequency is defined as follows: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000) and very rare (<1/10,000).
Slovenian: Neželeni učinki so navedeni po padajoči resnosti in njihova pogostnost je opredeljena takole: zelo pogosti: (≥ 1/10); pogosti: (≥ 1/100 do < 1/10); občasni: (≥ 1/1.000 do < 1/100); redki: (≥ 1/10.000 do < 1/1.000) in zelo redki: (< 1/10.000).
English: Turn the bottle upside down (figure 5).
Slovenian: Steklenico obrnite navzdol (slika 5).
English: NextPharma SAS, 17 Route de Meulan, F-78520 Limay, France.
Slovenian: NextPharma SAS, 17 Route de Meulan, F-78520 Limay, Francija ali
English: * The colourants are:
Slovenian: *Barvila so:
English: The following information is intended for healthcare professionals only: Directions for the proper use of Keppra is provided in section 3.
Slovenian: Naslednje informacije so namenjene samo zdravstvenemu osebju: Navodila za pravilno uporabo zdravila Keppra se nahajajo v poglavju 3.
English: • Wash the syringe with water only (figure 8).
Slovenian: • Sperite brizgo samo z vodo (slika 8).
English: • Turn the bottle the right way up (figure 6A).
Slovenian: • Obrnite steklenico pokonci (slika 6A).
English: • Empty the contents of the syringe in a glass of water or baby's bottle by pushing the piston to the bottom of the syringe (figure 7).
Slovenian: • Vsebino brizge spraznite v kozarec vode ali v steklenico za hranjenje otrok tako, da potisnete bat navzdol (slika 7).
English: • A small number of people being treated with anti-epileptics such as Keppra have had thoughts of harming or killing themselves.
Slovenian: • pri majhnem številu bolnikov, ki so se zdravili z antiepileptiki, kot je zdravilo Keppra, so se pojavile misli na samopoškodovanje ali samomor.
English: What Keppra is and what it is used for
Slovenian: Kaj je zdravilo Keppra in za kaj ga uporabljamo
English: Keppra is for intravenous use.
Slovenian: Zdravilo Keppra je za intravensko uporabo.
English: After measuring the correct dosage with an appropriate syringe, Keppra oral solution may be diluted in a glass of water or baby's bottle.
Slovenian: Po tem, ko ste izmerili pravilen odmerek z ustrezno brizgo, lahko peroralno raztopino zdravila Keppra razredčite v kozarcu vode ali v steklenici za hranjenje otrok.
English: Patients treated with levetiracetam should be monitored for developing psychiatric signs suggesting important mood and/or personality changes.
Slovenian: Bolnike, zdravljene z levetiracetamom, je treba spremljati glede razvoja psihiatričnih znakov, ki kažejo na pomembne spremembe v razpoloženju in/ali spremembe osebnosti.
English: • Take the syringe and put it in the adaptor opening (figure 4).
Slovenian: • Vzemite brizgo in jo dajte v odprtino adapterja (slika 4).
English: Keppra may impair your ability to drive or operate any tools or machinery, as it may make you feel sleepy.
Slovenian: Zdravilo Keppra lahko oslabi vašo sposobnost vožnje ali upravljanja z orodjem ali stroji, saj lahko povzroči zaspanost.
English: Instructions for use: • Open the bottle: press the cap and turn it anticlockwise (figure 1)
Slovenian: Navodila za uporabo: • Odprite steklenico: pritisnite zaporko in jo obrnite v nasprotni smeri urinega kazalca (slika1).
English: You should continue Keppra treatment for as long as your doctor has told you.
Slovenian: Zdravljenje z zdravilom Keppra morate nadaljevati tako dolgo, kot vam je naročil zdravnik.
English: Should your doctor decide to stop your Keppra treatment, he/she will instruct you about the gradual withdrawal of Keppra.
Slovenian: Če se bo vaš zdravnik odločil za prekinitev zdravljenja z zdravilom Keppra, vam bo dal napotke o postopni ukinitvi zdravila Keppra.
English: Levetiracetam may cause psychotic symptoms and behavioural abnormalities including irritability and aggressiveness.
Slovenian: Levetiracetam lahko povzroči psihotične simptome in vedenjske spremembe, vključno z razdražljivostjo in agresivnostjo.
English: Date of opening only for the outer carton
Slovenian: Datum odprtja (samo za škatlo)
English: These data are supplemented with the use of levetiracetam in corresponding openlabel extension studies, as well as post-marketing experience.
Slovenian: Ti podatki so dopolnjeni s podatki iz ustreznih odprtih, razširjenih študij o uporabi levetiracetama ter s postmarketinškimi podatki.
English: Keppra oral solution also contains maltitol.
Slovenian: Zdravilo Keppra peroralna raztopina vsebuje tudi maltitol.
English: Aluminium/PVC blister
Slovenian: Aluminij/PVC pretisni omot
English: Swallow Keppra tablets with a sufficient quantity of liquid (e.g. a glass of water).
Slovenian: Tablete zdravila Keppra zaužijte z dovolj tekočine (npr. s kozarcem vode).
English: Keppra must be administered twice a day, once in the morning and once in the evening, at about the same time each day.
Slovenian: Zdravilo Keppra morate prejeti dvakrat na dan, enkrat zjutraj in enkrat zvečer, vsak dan ob približno istem času.
English: If discontinuation is considered, please refer to section 4.2.
Slovenian: Če razmišljate o prekinitvi zdravljenja, glejte poglavje 4.2.
English: All other packs are available in standard aluminium/PVC blisters.
Slovenian: Ostala pakiranja so na voljo v standardnih aluminij/PVC pretisnih omotih.
English: Remove the syringe from the adaptor (figure 6B).
Slovenian: Odstranite brizgo iz adapterja (slika 6B).
English: Aesica Pharmaceuticals S.r.l., Via Praglia, 15, I-10044 Pianezza, Italy.
Slovenian: Aesica Pharmaceuticals S.r.l., Via Praglia, 15, I-10044 Pianezza, Italija.
English: You may take Keppra with or without food.
Slovenian: Zdravilo Keppra lahko vzamete s hrano ali brez.
English: It is therefore recommended to adjust the maintenance daily dose of Keppra, based on creatinine clearance in patients with moderate and severe renal impairment (see section 4.2).
Slovenian: Zato je priporočljivo dnevni vzdrževalni odmerek zdravila Keppra pri bolnikih z zmerno in hudo ledvično okvaro prilagoditi očistku kreatinina (glejte poglavje 4.2).
English: Insert the adaptor into the bottle neck (figure 3).
Slovenian: Vstavite adapter v vrat steklenice (slika 3).
English: 500 to 1,500 mg twice daily 500 to 1,000 mg twice daily 250 to 750 mg twice daily 250 to 500 mg twice daily 500 to 1,000 mg once daily
Slovenian: 500 do 1500 mg dvakrat na dan 500 do 1000 mg dvakrat na dan 250 do 750 mg dvakrat na dan 250 do 500 mg dvakrat na dan 500 do 1000 mg enkrat na dan(2)
English: Contains E216, E218 and maltitol liquid.
Slovenian: SEZNAM POMOŽNIH SNOVI Vsebuje E216, E218 in raztopino maltitola.
English: Keppra is used:
Slovenian: Zdravilo Keppra se uporablja:
English: You can switch from the film-coated tablets or from the oral solution to the intravenous formulation or reverse directly without dose adaptation.
Slovenian: Prehod od filmsko obloženih tablet ali od peroralne raztopine k intravenski obliki ali obratno je lahko neposreden brez prilagajanja odmerka.
English: Other medicines and Keppra
Slovenian: Druga zdravila in zdravilo Keppra
English: Dose and frequency (1) Infants 1 to less than 6 months
Slovenian: odmerjanje in pogostnost(1) Dojenčki od 1 do manj kot 6 mesecev
English: The recommended dose must be diluted in at least 100 ml of a compatible diluent and infused over 15-minutes.
Slovenian: Priporočen odmerek se mora razredčiti v vsaj 100 ml kompatibilnega topila in infundirano 15 minut.
English: • convulsion, balance disorder (equilibrium disorder), dizziness (sensation of unsteadiness),lethargy (lack of energy and enthusiasm), tremor (involuntary trembling);
Slovenian: • konvulzije, motnje ravnotežja, omotica (občutek nesigurnosti), letargija (pomanjkanje energije in navdušenja), tremor (nehoteno tresenje)
English: In all of the above cases Keppra oral solution should be used.
Slovenian: V vseh teh primerih se mora uporabiti zdravilo Keppra peroralna raztopina.
English: Since there was limited exposure for Keppra intravenous use and since oral and intravenous formulations are bioequivalent, the safety information of Keppra intravenous will rely on Keppra oral use.
Slovenian: Zaradi omejene izpostavljenosti zdravila Keppra za intravensko uporabo in bioekvivalence med peroralno in intravensko obliko se informacije o varnosti za zdravilo Keppra za intravensko uporabo navezujejo na zdravilo Keppra za peroralno uporabo.
English: Keppra concentrate is for intravenous use only and the recommended dose must be diluted in at least 100 ml of a compatible diluent and administered intravenously as a 15-minute intravenous infusion (see section 6.6).
Slovenian: Koncentrat zdravila Keppra je samo za intravensko uporabo, priporočeni odmerek mora biti razredčen v vsaj 100 ml kompatibilnega topila in uporabljen intravensko kot 15 -minutna intravenska infuzija (glejte poglavje 6.6).
English: Results related to behavioural and emotional functioning indicated a worsening in levetiracetam treated patients on aggressive behaviour as measured in a standardised and systematic way using a validated instrument (CBCL - Achenbach Child Behavior Checklist).
Slovenian: Rezultati, povezani z vedenjskimi in emocionalnimi funkcijami, kažejo pri bolnikih, ki se zdravijo z levetiracetamom, poslabšanje agresivnega obnašanja, ki se izmeri na standardiziran in sistematičen način z uporabo validiranega merskega instrumenta (CBCL - Achenbach Child Behavior Checklist).
English: UCB Pharma SA, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.
Slovenian: UCB Pharma SA, Chemin du Foriest, B-1420 Braine-l'Alleud, Belgija Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnete na predstavništvo imetnika dovoljenja za promet z zdravilom.
English: For doctors and nurses, more detailed direction for the proper use of Keppra is provided in section 6.
Slovenian: Za zdravnike in medicinske sestre so podrobna navodila za uporabo zdravila Keppra navedena v poglavju 6.